Electrical Stimulation for Ruptured Achilles Tendon
Trial Summary
What is the purpose of this trial?
This trial is testing NMES, a technique that uses electrical impulses to strengthen muscles, on patients with Achilles tendon ruptures. These patients often have long-term issues like weak calf muscles. NMES helps by making the muscles work, which supports better tendon healing. Neuromuscular electrical stimulation (NMES) has been used to improve muscle strength and activation in various conditions, including knee osteoarthritis, spinal cord injury, and muscle wasting in heart failure patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if your tendon rupture is associated with the use of fluoroquinolones (a type of antibiotic), you would be excluded from participating.
What data supports the effectiveness of the treatment NMES (Neuromuscular Electrical Stimulation) for ruptured Achilles tendon?
Is neuromuscular electrical stimulation (NMES) safe for humans?
How does NMES treatment differ from other treatments for ruptured Achilles tendon?
NMES (Neuromuscular Electrical Stimulation) is unique because it uses electrical impulses to stimulate muscle contractions, which can aid in muscle recovery and strength without the need for surgery. This approach is different from traditional treatments that often involve surgical repair or immobilization, as it focuses on enhancing muscle function and potentially speeding up rehabilitation.1251112
Eligibility Criteria
This trial is for individuals who have experienced an Achilles tendon rupture and are undergoing recovery. It's not suitable for those who can't understand English, were treated non-operatively, had ruptures related to fluoroquinolone antibiotics use, or have conditions like diabetes or poor leg circulation that affect healing. People with augmented surgical repairs or allergies to ultrasound gel aren't eligible either.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Neuromuscular Electrical Stimulation (NMES) is applied to the calf muscles, with stimulation levels increased weekly from 10 to 30 mA during the first 6 weeks after surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of heel rise ability, tendon length, and muscle cross-sectional area
Long-term Follow-up
Participants are further monitored for long-term outcomes such as tendon and muscle measurements and functional scores
Treatment Details
Interventions
- NMES
NMES is already approved in United States, European Union for the following indications:
- Muscle wasting and weakness after subarachnoid hemorrhage (SAH)
- Rehabilitation post-SAH
- Muscle weakness and wasting in critically ill patients
- Rehabilitation post-SAH
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penn State University
Lead Sponsor